🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the corporations hid alleged dangers that the pain reliever created to pediatric neurological development.

This legal action arrives four weeks after Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - referred to as acetaminophen - throughout gestation and autism in young ones.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he stated they "deceived the public by gaining financially from pain and pushing pills without regard for the potential hazards."

Kenvue says there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers misled for generations, deliberately risking numerous people to increase profits," the attorney general, a Republican, stated.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a established connection between taking acetaminophen and autism spectrum disorder."

Organizations speaking for physicians and healthcare providers share this view.

The leading OB-GYN organization has declared paracetamol - the key substance in acetaminophen - is among limited choices for expectant mothers to address discomfort and elevated temperature, which can pose serious health risks if ignored.

"In multiple decades of research on the use of acetaminophen in gestation, not a single reputable study has definitively established that the usage of acetaminophen in any trimester of gestation leads to neurological conditions in offspring," the association commented.

This legal action mentions latest statements from the Trump administration in asserting the medication is potentially dangerous.

In recent weeks, the former president caused concern from health experts when he advised expectant mothers to "struggle intensely" not to consume acetaminophen when ill.

Federal regulators then released a statement that doctors should think about restricting the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had vowed in spring to conduct "extensive scientific investigation" that would establish the source of autism spectrum disorder in a matter of months.

But experts warned that finding a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that influences how persons experience and relate to the world, and is recognized using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking US Senate - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

The case aims to force the companies "remove any commercial messaging" that states Tylenol is safe for women during pregnancy.

The court case mirrors the grievances of a assembly of mothers and fathers of minors with autism spectrum disorder and ADHD who sued the manufacturers of Tylenol in two years ago.

A federal judge dismissed the lawsuit, saying investigations from the parents' expert witnesses was not conclusive.